Table 5 Data about chronological age (CA) and dental age (DA) among the studies that evaluated vertical discrepancies related to sex
From: Association between dental age and malocclusions: a systematic review
Study ID | Criteria for DA evaluation | Malocclusion evaluated (criteria) | Sex | N | Mean CA | SD | Mean DA | SD | DA-CA | SD | Description of results |
|---|---|---|---|---|---|---|---|---|---|---|---|
Gottimukkala et al., 2012 [33] | Demirjian | Vertical (LAFH/TAFH ≥58%) | Male | 25 | 10.72 | 0.98 | 11.74 | 1.13 | NR | NR | • In the vertical group, both genders presented advanced DA in relation to the horizontal group. |
Female | 25 | 10.20 | 1.00 | 11.13 | 1.19 | NR | NR | ||||
Horizontal (LAFH/TAFH ≤56%) | Male | 25 | 11.04 | 0.89 | 10.30 | 1.34 | NR | NR | |||
Female | 25 | 10.72 | 1.02 | 9.78 | 1.12 | NR | NR | ||||
Goyal et al., 2011 [34] | Demirjian | Normal (SN-GoGn 32+2º; LAFH 60-62 mm; Jarabak ratio 62-65%) | Male | 25 | 9.58 | NR | 9.57 | NR | NR | NR | • In the vertical group, both genders presented advanced DA in relation to the horizontal group. • There no significant differences were found between vertical growing patients and horizontal growing patients were compared to patients with a normal growth pattern. • No difference was found in DA between males and females when compared inside the same growth pattern. |
Female | 25 | 9.33 | NR | 9.36 | NR | NR | NR | ||||
Vertical (SN-GoGn >34º; LAFH >62 mm; Jarabak ratio <62%) | Male | 25 | 9.42 | NR | 9.94 | NR | NR | NR | |||
Female | 25 | 9.06 | NR | 9.68 | NR | NR | NR | ||||
Horizontal (SN-GoGn >30º; LAFH <60 mm; Jarabak ratio >65%) | Male | 24 | 9.70 | NR | 9.22 | NR | NR | NR | |||
Female | 25 | 9.43 | NR | 9.05 | NR | NR | NR | ||||
Janson et al., 1998 [16] | Demirjian | Vertical (LAFH/TAFH= NR) | Male | 10 | 9.43 | 1.13 | 10.48 | 1.79 | NR | NR | • DA had a tendency to be more advanced in both genders in the vertical group as compared with the horizontal group. |
Female | 10 | 8.98 | 0.96 | 9.60 | 1.55 | NR | NR | ||||
Horizontal (LAFH/TAFH= NR) | Male | 10 | 9.51 | 1.11 | 9.96 | 1.40 | NR | NR | |||
Female | 10 | 8.98 | 0.89 | 9.04 | 1.27 | NR | NR | ||||
Jo et al., 2021 [5] | Demirjian | Normal (SN-GoMe 33-40º) | Male | 44 | 11.30 | 1.50 | 12.91 | 2.16 | NR | NR | • No difference was found among growth patterns and between genders. |
Female | 49 | 11.00 | 1.90 | 12.52 | 2.29 | NR | NR | ||||
Vertical (SN-GoMe >41º) | Male | 25 | 11.80 | 1.60 | 13.54 | 1.98 | NR | NR | |||
Female | 24 | 11.30 | 1.70 | 13.80 | 1.94 | NR | NR | ||||
Horizontal (SN-GoMe <33º) | Male | 27 | 12.00 | 1.30 | 12.23 | 1.74 | NR | NR | |||
Female | 15 | 11.10 | 2.10 | 11.91 | 2.03 | NR | NR |